Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Shares Issued: 2017-2024

Historic Shares Issued for Bicycle Therapeutics (BCYC) over the last 8 years, with Dec 2024 value amounting to $544.1 million.

  • Bicycle Therapeutics' Shares Issued rose 100.10% to $1,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$975,000, marking a year-over-year decrease of 100.18%. This contributed to the annual value of $544.1 million for FY2024, which is 118.22% up from last year.
  • Latest data reveals that Bicycle Therapeutics reported Shares Issued of $544.1 million as of FY2024, which was up 118.22% from $249.3 million recorded in FY2023.
  • In the past 5 years, Bicycle Therapeutics' Shares Issued registered a high of $544.1 million during FY2024, and its lowest value of $5.7 million during FY2022.
  • For the 3-year period, Bicycle Therapeutics' Shares Issued averaged around $266.4 million, with its median value being $249.3 million (2023).
  • As far as peak fluctuations go, Bicycle Therapeutics' Shares Issued slumped by 98.04% in 2022, and later skyrocketed by 4,272.17% in 2023.
  • Over the past 5 years, Bicycle Therapeutics' Shares Issued (Yearly) stood at $48.1 million in 2020, then skyrocketed by 504.40% to $291.0 million in 2021, then plummeted by 98.04% to $5.7 million in 2022, then spiked by 4,272.17% to $249.3 million in 2023, then skyrocketed by 118.22% to $544.1 million in 2024.